Hyperthermia and radiotherapy in the management of head and neck cancers: A systematic review and meta-analysis

Purpose: A systematic review and meta-analysis was conducted to evaluate the outcome of controlled clinical trials in head and neck cancers (HNCs) using hyperthermia and radiotherapy versus radiotherapy alone. Material and methods: A total of 498 abstracts were screened from four databases and hand...

Full description

Saved in:

Bibliographic Details
Published in:	International journal of hyperthermia Vol. 32; no. 1; pp. 31 - 40
Main Authors:	Datta, Niloy R., Rogers, Susanne, Ordóñez, Silvia Gómez, Puric, Emsad, Bodis, Stephan
Format:	Journal Article
Language:	English
Published:	England Taylor & Francis 02.01.2016
Subjects:	Clinical Trials as Topic Combined Modality Therapy Head and neck cancers Head and Neck Neoplasms - radiotherapy Head and Neck Neoplasms - therapy Humans hyperthermia Hyperthermia, Induced meta-analysis radiotherapy systematic review meta-analysis radiotherapy hyperthermia Head and neck cancers systematic review
ISSN:	0265-6736, 1464-5157
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Abstract	Purpose: A systematic review and meta-analysis was conducted to evaluate the outcome of controlled clinical trials in head and neck cancers (HNCs) using hyperthermia and radiotherapy versus radiotherapy alone. Material and methods: A total of 498 abstracts were screened from four databases and hand searched as per the PRISMA guidelines. Only two-arm studies treating HNCs with either radiotherapy alone, or hyperthermia and radiotherapy without concurrent chemotherapy or surgery were considered. The evaluated end point was complete response (CR). Results: Following a detailed screening of the titles, abstracts and full text papers, six articles fulfilling the above eligibility criteria were considered. In total 451 clinical cases from six studies were included in the meta-analysis. Five of six trials were randomised. The overall CR with radiotherapy alone was 39.6% (92/232) and varied between 31.3% and 46.9% across the six trials. With thermoradiotherapy, the overall CR reported was 62.5% (137/219), (range 33.9-83.3%). The odds ratio was 2.92 (95% CI: 1.58-5.42, p = 0.001); the risk ratio was 1.61 (95% CI: 1.32-1.97, p < 0.0001) and the risk difference was 0.25 (95% CI: 0.12-0.39, p < 0.0001), all in favour of combined treatment with hyperthermia and radiotherapy over radiotherapy alone. Acute and late grade III/IV toxicities were reported to be similar in both the groups. Conclusions: Hyperthermia along with radiotherapy enhances the likelihood of CR in HNCs by around 25% compared to radiotherapy alone with no significant additional acute and late morbidities. This level I evidence should justify the integration of hyperthermia into the multimodality therapy of HNCs.
AbstractList	Purpose: A systematic review and meta-analysis was conducted to evaluate the outcome of controlled clinical trials in head and neck cancers (HNCs) using hyperthermia and radiotherapy versus radiotherapy alone. Material and methods: A total of 498 abstracts were screened from four databases and hand searched as per the PRISMA guidelines. Only two-arm studies treating HNCs with either radiotherapy alone, or hyperthermia and radiotherapy without concurrent chemotherapy or surgery were considered. The evaluated end point was complete response (CR). Results: Following a detailed screening of the titles, abstracts and full text papers, six articles fulfilling the above eligibility criteria were considered. In total 451 clinical cases from six studies were included in the meta-analysis. Five of six trials were randomised. The overall CR with radiotherapy alone was 39.6% (92/232) and varied between 31.3% and 46.9% across the six trials. With thermoradiotherapy, the overall CR reported was 62.5% (137/219), (range 33.9-83.3%). The odds ratio was 2.92 (95% CI: 1.58-5.42, p = 0.001); the risk ratio was 1.61 (95% CI: 1.32-1.97, p < 0.0001) and the risk difference was 0.25 (95% CI: 0.12-0.39, p < 0.0001), all in favour of combined treatment with hyperthermia and radiotherapy over radiotherapy alone. Acute and late grade III/IV toxicities were reported to be similar in both the groups. Conclusions: Hyperthermia along with radiotherapy enhances the likelihood of CR in HNCs by around 25% compared to radiotherapy alone with no significant additional acute and late morbidities. This level I evidence should justify the integration of hyperthermia into the multimodality therapy of HNCs. PURPOSEA systematic review and meta-analysis was conducted to evaluate the outcome of controlled clinical trials in head and neck cancers (HNCs) using hyperthermia and radiotherapy versus radiotherapy alone.MATERIAL AND METHODSA total of 498 abstracts were screened from four databases and hand searched as per the PRISMA guidelines. Only two-arm studies treating HNCs with either radiotherapy alone, or hyperthermia and radiotherapy without concurrent chemotherapy or surgery were considered. The evaluated end point was complete response (CR).RESULTSFollowing a detailed screening of the titles, abstracts and full text papers, six articles fulfilling the above eligibility criteria were considered. In total 451 clinical cases from six studies were included in the meta-analysis. Five of six trials were randomised. The overall CR with radiotherapy alone was 39.6% (92/232) and varied between 31.3% and 46.9% across the six trials. With thermoradiotherapy, the overall CR reported was 62.5% (137/219), (range 33.9-83.3%). The odds ratio was 2.92 (95% CI: 1.58-5.42, p = 0.001); the risk ratio was 1.61 (95% CI: 1.32-1.97, p < 0.0001) and the risk difference was 0.25 (95% CI: 0.12-0.39, p < 0.0001), all in favour of combined treatment with hyperthermia and radiotherapy over radiotherapy alone. Acute and late grade III/IV toxicities were reported to be similar in both the groups.CONCLUSIONSHyperthermia along with radiotherapy enhances the likelihood of CR in HNCs by around 25% compared to radiotherapy alone with no significant additional acute and late morbidities. This level I evidence should justify the integration of hyperthermia into the multimodality therapy of HNCs. A systematic review and meta-analysis was conducted to evaluate the outcome of controlled clinical trials in head and neck cancers (HNCs) using hyperthermia and radiotherapy versus radiotherapy alone. A total of 498 abstracts were screened from four databases and hand searched as per the PRISMA guidelines. Only two-arm studies treating HNCs with either radiotherapy alone, or hyperthermia and radiotherapy without concurrent chemotherapy or surgery were considered. The evaluated end point was complete response (CR). Following a detailed screening of the titles, abstracts and full text papers, six articles fulfilling the above eligibility criteria were considered. In total 451 clinical cases from six studies were included in the meta-analysis. Five of six trials were randomised. The overall CR with radiotherapy alone was 39.6% (92/232) and varied between 31.3% and 46.9% across the six trials. With thermoradiotherapy, the overall CR reported was 62.5% (137/219), (range 33.9-83.3%). The odds ratio was 2.92 (95% CI: 1.58-5.42, p = 0.001); the risk ratio was 1.61 (95% CI: 1.32-1.97, p < 0.0001) and the risk difference was 0.25 (95% CI: 0.12-0.39, p < 0.0001), all in favour of combined treatment with hyperthermia and radiotherapy over radiotherapy alone. Acute and late grade III/IV toxicities were reported to be similar in both the groups. Hyperthermia along with radiotherapy enhances the likelihood of CR in HNCs by around 25% compared to radiotherapy alone with no significant additional acute and late morbidities. This level I evidence should justify the integration of hyperthermia into the multimodality therapy of HNCs.
Author	Rogers, Susanne Ordóñez, Silvia Gómez Puric, Emsad Datta, Niloy R. Bodis, Stephan
Author_xml	– sequence: 1 givenname: Niloy R. surname: Datta fullname: Datta, Niloy R. email: niloyranjan.datta@ksa.ch, nrdatta@yahoo.com organization: Centre for Radiation Oncology – sequence: 2 givenname: Susanne surname: Rogers fullname: Rogers, Susanne organization: Centre for Radiation Oncology – sequence: 3 givenname: Silvia Gómez surname: Ordóñez fullname: Ordóñez, Silvia Gómez organization: Centre for Radiation Oncology – sequence: 4 givenname: Emsad surname: Puric fullname: Puric, Emsad organization: Centre for Radiation Oncology – sequence: 5 givenname: Stephan surname: Bodis fullname: Bodis, Stephan organization: Department of Radiation Oncology, University Hospital
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/26928474$$D View this record in MEDLINE/PubMed
BookMark	eNqFkU1v1DAURS1URKeFnwDykk2mduKPCWyoKqCVKnVT1tGL_UINiT3Ynlb59zidaRcsysrW0zl3ce8JOfLBIyHvOVs3nLVnrFZS6Uata8blulxaLdQrsuJCiUpyqY_IamGqBTomJyn9YowJWes35LhWbb0RWqxIuJy3GPMdxskBBW9pBOvCcoDtTJ2n5Usn8PATJ_SZhoHeIdhH1KP5TQ14gzF9ouc0zSnjBNkZGvHe4cMjNWGGqgSMc3LpLXk9wJjw3eE9JT--fb29uKyub75fXZxfV0aKNlcWmWj7GnWvhNStNtAbqbnsQdSKN42y9UYKVK2xNWsE9MjBMmNAbLgdBtGcko_73G0Mf3aYcje5ZHAcwWPYpY5r1babUgIr6IcDuusntN02ugni3D2VVAC5B0wMKUUcnhHOumWM7mmMbhmjO4xRvM__eMbl0k7wOYIb_2t_2dvODyFO8BDiaLsM8xjiEEvpLi36SxF_AaTuoys
CitedBy_id	crossref_primary_10_1016_j_ijrobp_2018_09_037 crossref_primary_10_3390_cancers17050899 crossref_primary_10_3390_cancers15030742 crossref_primary_10_1002_mmce_21238 crossref_primary_10_1016_j_ejca_2021_01_039 crossref_primary_10_1002_mp_15220 crossref_primary_10_1049_mia2_12226 crossref_primary_10_1002_mp_17248 crossref_primary_10_1016_j_ultrasmedbio_2018_12_007 crossref_primary_10_1177_1534735420932648 crossref_primary_10_2340_1651_226X_2024_41035 crossref_primary_10_3390_cancers15133388 crossref_primary_10_1109_JERM_2017_2766569 crossref_primary_10_1109_JERM_2018_2808678 crossref_primary_10_3389_fonc_2024_1428065 crossref_primary_10_1186_s13014_017_0923_8 crossref_primary_10_1007_s40430_024_05264_4 crossref_primary_10_3390_cancers13133277 crossref_primary_10_1103_PhysRevApplied_15_054007 crossref_primary_10_3389_fonc_2020_01690 crossref_primary_10_1073_pnas_1700790114 crossref_primary_10_3390_cancers13225617 crossref_primary_10_3390_ma15197036 crossref_primary_10_2217_3dp_2021_0024 crossref_primary_10_1088_2057_1976_2_5_055002 crossref_primary_10_3390_cancers15051394 crossref_primary_10_3390_bioengineering12010014 crossref_primary_10_1080_02656736_2021_2024280 crossref_primary_10_3390_app13127317 crossref_primary_10_3390_cancers13236149 crossref_primary_10_1109_JERM_2020_3042711 crossref_primary_10_3390_ijms25084270 crossref_primary_10_1109_TAP_2022_3164207 crossref_primary_10_1016_j_brachy_2025_02_002 crossref_primary_10_1111_vco_12923 crossref_primary_10_1016_j_jconrel_2022_02_003 crossref_primary_10_3389_fonc_2017_00132 crossref_primary_10_3390_nano8060401 crossref_primary_10_3390_ijms21176270 crossref_primary_10_1016_j_ctrv_2016_09_016 crossref_primary_10_1109_TBME_2016_2627941 crossref_primary_10_3389_fonc_2025_1552337 crossref_primary_10_3892_ijo_2018_4622 crossref_primary_10_3390_cancers15010113 crossref_primary_10_1007_s00339_024_07803_1 crossref_primary_10_1109_JERM_2019_2959710 crossref_primary_10_1016_j_jmmm_2021_168300 crossref_primary_10_1109_JERM_2020_3043383 crossref_primary_10_1109_JERM_2020_3047980 crossref_primary_10_1016_j_critrevonc_2020_103088 crossref_primary_10_1016_j_ctro_2021_01_008 crossref_primary_10_3390_ijms25010423 crossref_primary_10_1088_1361_6560_abd41a crossref_primary_10_3390_molecules26154591 crossref_primary_10_1016_j_ctrv_2015_05_009 crossref_primary_10_1016_j_addr_2020_01_003 crossref_primary_10_1007_s00262_025_04029_9 crossref_primary_10_2528_PIER18071704 crossref_primary_10_3748_wjg_v23_i30_5530 crossref_primary_10_1016_j_rpor_2020_02_008 crossref_primary_10_3390_cancers11081183 crossref_primary_10_4103_UROS_UROS_6_22 crossref_primary_10_1088_1361_6463_accc97 crossref_primary_10_3892_ijo_2018_4439 crossref_primary_10_1016_j_ajoms_2025_06_003 crossref_primary_10_3389_fonc_2020_00819 crossref_primary_10_3390_cancers14040901 crossref_primary_10_1155_2019_9435389 crossref_primary_10_1016_j_radonc_2019_05_002 crossref_primary_10_1038_s41467_025_59748_5 crossref_primary_10_3390_cancers16233908 crossref_primary_10_3390_cancers14071701 crossref_primary_10_1016_j_ijrobp_2020_02_030 crossref_primary_10_1080_02656736_2024_2447952 crossref_primary_10_1007_s00066_025_02385_0 crossref_primary_10_1016_j_cps_2021_05_007 crossref_primary_10_3390_cancers15020346 crossref_primary_10_1186_s40349_018_0115_5 crossref_primary_10_1016_j_addr_2020_03_004 crossref_primary_10_3390_cancers17121980 crossref_primary_10_3390_cancers14020315 crossref_primary_10_1016_j_addr_2020_03_006 crossref_primary_10_1088_1361_6560_aaca10 crossref_primary_10_3390_biom11111604 crossref_primary_10_1016_j_critrevonc_2019_04_023 crossref_primary_10_3390_nano8050306 crossref_primary_10_3389_fonc_2019_00889 crossref_primary_10_3892_ijo_2024_5704
Cites_doi	10.1093/jjco/hyu209 10.1667/0033-7587(2001)155[0515:IOTOBM]2.0.CO;2 10.3109/02656736.2013.790092 10.1200/JCO.2009.22.4659 10.1016/j.radonc.2011.03.004 10.3109/02656736.2012.689087 10.1088/0031-9155/58/17/5997 10.3109/02656738509029286 10.1185/03007995.2011.633989 10.1002/1097-0142(19870901)60:5<950::AID-CNCR2820600506>3.0.CO;2-Z 10.7314/APJCP.2013.14.12.7395 10.1097/00000421-199104000-00008 10.1016/j.radonc.2014.11.011 10.3109/02656739009140944 10.1016/j.radonc.2013.11.010 10.1177/1430.15815 10.1002/1097-0142(20010201)91:3<548::AID-CNCR1033>3.0.CO;2-A 10.1016/j.radonc.2014.01.027 10.1016/0360-3016(90)90466-W 10.1016/S0360-3016(99)00362-4 10.1080/02656730902852677 10.1080/02656730500271668 10.3109/02656736.2010.503982 10.3109/02656739809018247 10.1016/j.ctrv.2015.05.009 10.2307/2533446 10.1016/j.ejca.2014.07.001 10.1080/02656730701378684 10.1016/0360-3016(94)90154-6 10.1016/S0167-8140(97)00134-5 10.1007/s00066-014-0709-y 10.1016/0360-3016(89)90471-9 10.1016/j.ijrobp.2010.06.028 10.1016/j.radonc.2013.11.004 10.3109/02656738609012394 10.1118/1.4901270 10.1016/j.ygyno.2006.01.058 10.1038/onc.2013.25 10.1016/0360-3016(88)90341-0 10.4103/0973-1482.77101 10.1016/S1470-2045(09)70311-0 10.1016/j.ctrv.2010.03.010 10.3109/02656736.2014.981299 10.2217/fon.15.53 10.3109/02656736.2013.783934 10.1136/bmj.b2700 10.1016/j.radonc.2009.04.014 10.1186/1748-717X-6-70 10.1016/S1470-2045(09)70023-3 10.1158/1078-0432.CCR-04-0133
ContentType	Journal Article
Copyright	2015 Taylor & Francis. 2015
Copyright_xml	– notice: 2015 Taylor & Francis. 2015
DBID	AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8
DOI	10.3109/02656736.2015.1099746
DatabaseName	CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic
DatabaseTitleList	MEDLINE - Academic MEDLINE
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
EISSN	1464-5157
EndPage	40
ExternalDocumentID	26928474 10_3109_02656736_2015_1099746 1099746
Genre	Article Meta-Analysis Systematic Review Journal Article
GroupedDBID	--- 00X 0YH 29J 36B 4.4 5GY 5RE AALUX AAPXX AATTQ ABDBF ABLKL ABUPF ACGEJ ACGFS ACUHS ADCVX ADRBQ ADXPE AENEX AFKVX AGYJP AIJEM AJWEG ALMA_UNASSIGNED_HOLDINGS AQTUD BABNJ BLEHA BOHLJ CCCUG CS3 DKSSO DU5 EAP EAS EBB EBC EBD EBO EBS EBX EHN EJD EMB EMK EMOBN EPL EPT ESX F5P GROUPED_DOAJ H13 HZ~ I-F KRBQP KSSTO KTTOD KWAYT L7B M4Z O9- P2P QZIEQ Q~Q SV3 TDBHL TFDNU TFL TFW TH9 TUS V1S ~1N AAYXX CITATION 53G 5VS AALIY ADBBV AWYRJ BCNDV BRMBE CAG CGR COF CUY CVF CYYVM CZDIS DRXRE ECM EIF M44 NPM QQXMO UDS ZGI 7X8
ID	FETCH-LOGICAL-c549t-de049b2e7b645797cabc5715ba4261336d2854e69cd2034abe1ad0cca481dff43
IEDL.DBID	TFW
ISICitedReferencesCount	117
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000371912800005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	0265-6736
IngestDate	Fri Jul 11 16:35:18 EDT 2025 Sat Jun 28 01:34:47 EDT 2025 Sat Nov 29 06:35:09 EST 2025 Tue Nov 18 22:21:37 EST 2025 Mon Oct 20 23:30:47 EDT 2025
IsDoiOpenAccess	false
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	1
Keywords	meta-analysis radiotherapy hyperthermia Head and neck cancers systematic review
Language	English
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c549t-de049b2e7b645797cabc5715ba4261336d2854e69cd2034abe1ad0cca481dff43
Notes	SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Review-1 ObjectType-Article-3 ObjectType-Undefined-4
OpenAccessLink	https://www.tandfonline.com/doi/pdf/10.3109/02656736.2015.1099746?needAccess=true
PMID	26928474
PQID	1769982840
PQPubID	23479
PageCount	10
ParticipantIDs	crossref_primary_10_3109_02656736_2015_1099746 proquest_miscellaneous_1769982840 pubmed_primary_26928474 crossref_citationtrail_10_3109_02656736_2015_1099746 informaworld_taylorfrancis_310_3109_02656736_2015_1099746
PublicationCentury	2000
PublicationDate	2016-01-02
PublicationDateYYYYMMDD	2016-01-02
PublicationDate_xml	– month: 01 year: 2016 text: 2016-01-02 day: 02
PublicationDecade	2010
PublicationPlace	England
PublicationPlace_xml	– name: England
PublicationTitle	International journal of hyperthermia
PublicationTitleAlternate	Int J Hyperthermia
PublicationYear	2016
Publisher	Taylor & Francis
Publisher_xml	– name: Taylor & Francis
References	CIT0030 CIT0032 CIT0031 CIT0034 CIT0033 Baujat B (CIT0002) 2010; 12 CIT0036 CIT0035 CIT0038 CIT0037 CIT0039 CIT0041 Wen QL (CIT0021) 2014; 100 CIT0040 CIT0043 CIT0042 CIT0001 CIT0045 CIT0044 CIT0003 CIT0047 CIT0005 CIT0049 CIT0004 CIT0048 CIT0007 CIT0006 CIT0009 CIT0008 CIT0050 CIT0052 CIT0051 CIT0010 CIT0054 CIT0053 CIT0012 CIT0055 Brizel DM (CIT0011) 1996; 56 CIT0014 CIT0013 CIT0016 CIT0015 CIT0018 CIT0017 CIT0019 CIT0020 CIT0023 CIT0022 CIT0025 CIT0024 CIT0027 CIT0026
References_xml	– ident: CIT0001 doi: 10.1093/jjco/hyu209 – ident: CIT0009 doi: 10.1667/0033-7587(2001)155[0515:IOTOBM]2.0.CO;2 – ident: CIT0050 doi: 10.3109/02656736.2013.790092 – ident: CIT0043 doi: 10.1200/JCO.2009.22.4659 – ident: CIT0005 doi: 10.1016/j.radonc.2011.03.004 – ident: CIT0012 doi: 10.3109/02656736.2012.689087 – ident: CIT0049 doi: 10.1088/0031-9155/58/17/5997 – ident: CIT0014 doi: 10.3109/02656738509029286 – ident: CIT0004 doi: 10.1185/03007995.2011.633989 – ident: CIT0026 doi: 10.1002/1097-0142(19870901)60:5<950::AID-CNCR2820600506>3.0.CO;2-Z – ident: CIT0018 doi: 10.7314/APJCP.2013.14.12.7395 – ident: CIT0024 doi: 10.1097/00000421-199104000-00008 – ident: CIT0039 doi: 10.1016/j.radonc.2014.11.011 – volume: 12 start-page: CD002026 year: 2010 ident: CIT0002 publication-title: Cochrane Database Syst Rev – ident: CIT0025 doi: 10.3109/02656739009140944 – ident: CIT0032 doi: 10.1016/j.radonc.2013.11.010 – volume: 100 start-page: 49 year: 2014 ident: CIT0021 publication-title: Tumori doi: 10.1177/1430.15815 – ident: CIT0033 doi: 10.1002/1097-0142(20010201)91:3<548::AID-CNCR1033>3.0.CO;2-A – ident: CIT0052 doi: 10.1016/j.radonc.2014.01.027 – ident: CIT0037 doi: 10.1016/0360-3016(90)90466-W – ident: CIT0013 doi: 10.1016/S0360-3016(99)00362-4 – ident: CIT0047 doi: 10.1080/02656730902852677 – ident: CIT0008 doi: 10.1080/02656730500271668 – volume: 56 start-page: 5347 year: 1996 ident: CIT0011 publication-title: Cancer Res – ident: CIT0019 doi: 10.3109/02656736.2010.503982 – ident: CIT0020 doi: 10.3109/02656739809018247 – ident: CIT0007 doi: 10.1016/j.ctrv.2015.05.009 – ident: CIT0030 doi: 10.2307/2533446 – ident: CIT0048 doi: 10.1016/j.ejca.2014.07.001 – ident: CIT0038 doi: 10.1080/02656730701378684 – ident: CIT0023 doi: 10.1016/0360-3016(94)90154-6 – ident: CIT0016 doi: 10.1016/S0167-8140(97)00134-5 – ident: CIT0053 doi: 10.1007/s00066-014-0709-y – ident: CIT0036 doi: 10.1016/0360-3016(89)90471-9 – ident: CIT0040 doi: 10.1016/j.ijrobp.2010.06.028 – ident: CIT0006 doi: 10.1016/j.radonc.2013.11.004 – ident: CIT0017 doi: 10.3109/02656738609012394 – ident: CIT0051 doi: 10.1118/1.4901270 – ident: CIT0042 doi: 10.1016/j.ygyno.2006.01.058 – ident: CIT0041 doi: 10.1038/onc.2013.25 – ident: CIT0015 doi: 10.1016/0360-3016(88)90341-0 – ident: CIT0022 doi: 10.4103/0973-1482.77101 – ident: CIT0031 doi: 10.1016/S1470-2045(09)70311-0 – ident: CIT0044 doi: 10.1016/j.ctrv.2010.03.010 – ident: CIT0054 doi: 10.3109/02656736.2014.981299 – ident: CIT0045 doi: 10.2217/fon.15.53 – ident: CIT0055 doi: 10.3109/02656736.2013.783934 – ident: CIT0027 doi: 10.1136/bmj.b2700 – ident: CIT0003 doi: 10.1016/j.radonc.2009.04.014 – ident: CIT0034 doi: 10.1186/1748-717X-6-70 – ident: CIT0035 doi: 10.1016/S1470-2045(09)70023-3 – ident: CIT0010 doi: 10.1158/1078-0432.CCR-04-0133
SSID	ssj0004527
Score	2.4741364
SecondaryResourceType	review_article
Snippet	Purpose: A systematic review and meta-analysis was conducted to evaluate the outcome of controlled clinical trials in head and neck cancers (HNCs) using... A systematic review and meta-analysis was conducted to evaluate the outcome of controlled clinical trials in head and neck cancers (HNCs) using hyperthermia... PURPOSEA systematic review and meta-analysis was conducted to evaluate the outcome of controlled clinical trials in head and neck cancers (HNCs) using...
SourceID	proquest pubmed crossref informaworld
SourceType	Aggregation Database Index Database Enrichment Source Publisher
StartPage	31
SubjectTerms	Clinical Trials as Topic Combined Modality Therapy Head and neck cancers Head and Neck Neoplasms - radiotherapy Head and Neck Neoplasms - therapy Humans hyperthermia Hyperthermia, Induced meta-analysis radiotherapy systematic review
Title	Hyperthermia and radiotherapy in the management of head and neck cancers: A systematic review and meta-analysis
URI	https://www.tandfonline.com/doi/abs/10.3109/02656736.2015.1099746 https://www.ncbi.nlm.nih.gov/pubmed/26928474 https://www.proquest.com/docview/1769982840
Volume	32
WOSCitedRecordID	wos000371912800005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVAWR databaseName: Taylor & Francis customDbUrl: eissn: 1464-5157 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0004527 issn: 0265-6736 databaseCode: TFW dateStart: 19850101 isFulltext: true titleUrlDefault: https://www.tandfonline.com providerName: Taylor & Francis
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LT-MwELYAoRUXnrtQHpWRuGY3aey44YYQVS8gDiB6i_yUqqUpSlMk_j0ztlvgwHJYbomUiRPb45nPnvmGkLNS5EWm0zTpgy1KmDAOVKpIE1M6JVJrldHSF5sQNzf90ai8jdGEsxhWiRjaBaIIv1ajckvlK5Agj-UfgA0cw5EwMIsjHxL4xEi6DaYfVfNu8PCeL1yEXRbug9xDDs_nb_lgnT5wl37ugXpLNNj6hn_YJpvRDaUXYd7skBVb75If1_GgfY9Mh4BPG3QOJ2NJoRXaSDOO2VovdFxTuKSTZewMnToKy7rxj9ZW_6Uap1MzO6cX9I0tmoZMGf_UxLYykZET5Se5H1zdXQ6TWJsh0YAo28RYgBaqZ4UqGBel0FJpLjKuJGKyPC8MpmbaotSml-ZMKptJk2rkUM-Mcyz_RdbqaW0PCGWp5qV1gIilYgCS-7ni1lmpciUYN3mHsMWYVDoSl2P9jMcKAAx2ZrXozAo7s4qd2SG_l2JPgbnjK4Hy_YBXrd8ycaG-Ccr9U_Z0MTsq0E88dJG1nc5nVSYKQLTgBKQdsh-mzfJzekWJ3gE7_I-Wj8gG3IZdod4xWWubuT0h6_q5Hc-aLlkVo37X68Qrw3wFvA
linkProvider	Taylor & Francis
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3fb9MwELZgTIyXsQGDAmNG4jXMaey45m2aqDqx9amIvVn-KVXQFKUZEv89d3ZauofBA7xFSi5Ozmf7vvPdZ0LeKVnVpWOsGMFaVHDpIwypmhVeRStZCNY7kw6bkNPp6PpabdfCYFolYuiYiSLSXI2DG4PRpwliMnUKuEFgPhJmZgkkRAKnuL5PHghYa5E_fzb-ss0YLnOcRaQ091zFc_drbq1Pt9hL7_ZB01o0fvw__uKA7PeeKD3LpnNI7oXmCXl41e-1PyXLCUDUFv3DxdxQaIa2xs_7gq2fdN5QuKSLTfoMXUYKM7tPjzbBfaUOLapdfaBn9DdhNM3FMumpRehMYXpalGfk8_jj7HxS9MczFA5AZVf4AOjCDoO0NRdSSWesE7IU1iAsq6raY3VmqJXzQ1ZxY0NpPHNIo176GHl1RHaaZRNeEMqZEypEAMXGcsDJo8qKEIOxlZVc-GpA-LpTtOu5y_EIjW8aMAwqU6-VqVGZulfmgLzfiH3P5B1_E1DbPa67FDWJ-YgTlPuj7Nu1eWgYorjvYpqwvFnpUtYAasEPYAPyPNvN5nOGtUIHgb_8h5ZPyN5kdnWpLy-mn16RR3ArB4mGr8lO196EY7LrfnTzVfsmDY1fK7EI_g
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZKi6peKO8uFDBSr6HOxo81t6rtqghY9VBEb5af0go2u8qmSPx7xo9d2kPLgd4iJRMn4xl7Pnv8DUIHUjS8toRUI5iLKipcAJfipHIyGEG8N87qVGxCTCajy0t5XrIJlyWtMmLokIki0lgdnXvhwmFCmEQeAmxgMR0pJmaxyIcEMTF_gLYgdObRyC_G368Thou8zMJSlns-xHP7a25MTzfIS28PQdNUNN69h594jB6VOBQfZcN5gjZ8-xRtfy077c_Q_AwAahejw9lUY2gFd9pNy3Gt33jaYrjEs3XyDJ4HDOO6S4-23v7ANtpTt_yIj_Bfumicj8qkp2a-15UupCjP0bfx6cXxWVWKM1QWIGVfOQ_Ywgy9MJwyIYXVxjJRM6MjKGsa7uLZTM-ldUPSUG18rR2xkUS9diHQ5gXabOet30OYEsukDwCJtaGAkkeNYT54bRojKHPNANFVnyhbmMtjAY2fChBMVKZaKVNFZaqizAH6sBZbZOqOfwnI6x2u-rRmEnKBkyh3p-z7lXUocNC466JbP79aqlpwgLQQBZABepnNZv05Qy5jeEBf_UfL79D2-clYffk0-fwa7cCdvEI03EebfXfl36CH9lc_XXZvk2P8Af4xB7A
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hyperthermia+and+radiotherapy+in+the+management+of+head+and+neck+cancers%3A+A+systematic+review+and+meta-analysis&rft.jtitle=International+journal+of+hyperthermia&rft.au=Datta%2C+Niloy+R&rft.au=Rogers%2C+Susanne&rft.au=Ord%C3%B3%C3%B1ez%2C+Silvia+G%C3%B3mez&rft.au=Puric%2C+Emsad&rft.date=2016-01-02&rft.eissn=1464-5157&rft.volume=32&rft.issue=1&rft.spage=31&rft.epage=40&rft_id=info:doi/10.3109%2F02656736.2015.1099746&rft.externalDBID=NO_FULL_TEXT
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0265-6736&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0265-6736&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0265-6736&client=summon